Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results

<p>Company reported positive clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study Positive benefits were observed across a number of clinical endpoints including pruritus, Investigator skin scoring system and patient global assessment No safety concerns have been observed to date in either ongoing clinical study Quoin expects its cash […]</p>
<p>The post <a href="https://forextv.com/top-news/quoin-pharmaceuticals-provides-corporate-update-and-announces-third-quarter-2023-financial-results/">Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>